302 related articles for article (PubMed ID: 24320497)
1. Tomotherapy treatment plan quality assurance: the impact of applied criteria on passing rate in gamma index method.
Bresciani S; Di Dia A; Maggio A; Cutaia C; Miranti A; Infusino E; Stasi M
Med Phys; 2013 Dec; 40(12):121711. PubMed ID: 24320497
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
[TBL] [Abstract][Full Text] [Related]
3. Gamma analysis dependence on specified low-dose thresholds for VMAT QA.
Song JH; Kim MJ; Park SH; Lee SR; Lee MY; Lee DS; Suh TS
J Appl Clin Med Phys; 2015 Nov; 16(6):263-272. PubMed ID: 26699582
[TBL] [Abstract][Full Text] [Related]
4. Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans.
McKenzie EM; Balter PA; Stingo FC; Jones J; Followill DS; Kry SF
Med Phys; 2014 Dec; 41(12):121702. PubMed ID: 25471949
[TBL] [Abstract][Full Text] [Related]
5. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
6. Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification.
Infusino E; Mameli A; Conti R; Gaudino D; Stimato G; Bellesi L; D'Angelillo RM; Ramella S; Benassi M; Trodella L
Med Dosim; 2014; 39(3):276-81. PubMed ID: 25088815
[TBL] [Abstract][Full Text] [Related]
7. IMRT QA: Selecting gamma criteria based on error detection sensitivity.
Steers JM; Fraass BA
Med Phys; 2016 Apr; 43(4):1982. PubMed ID: 27036593
[TBL] [Abstract][Full Text] [Related]
8. Clinical implementation of Dosimetry Check™ for TomoTherapy
Chung E; Kwon D; Park T; Kang H; Chung Y
J Appl Clin Med Phys; 2018 Nov; 19(6):193-199. PubMed ID: 30354001
[TBL] [Abstract][Full Text] [Related]
9. A study on correlation between 2D and 3D gamma evaluation metrics in patient-specific quality assurance for VMAT.
Rajasekaran D; Jeevanandam P; Sukumar P; Ranganathan A; Johnjothi S; Nagarajan V
Med Dosim; 2014; 39(4):300-8. PubMed ID: 24910246
[TBL] [Abstract][Full Text] [Related]
10. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
Park SY; Kim IH; Ye SJ; Carlson J; Park JM
Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.
Li G; Wu K; Peng G; Zhang Y; Bai S
Med Dosim; 2014; 39(4):309-13. PubMed ID: 24958705
[TBL] [Abstract][Full Text] [Related]
12. Deep nets vs expert designed features in medical physics: An IMRT QA case study.
Interian Y; Rideout V; Kearney VP; Gennatas E; Morin O; Cheung J; Solberg T; Valdes G
Med Phys; 2018 Jun; 45(6):2672-2680. PubMed ID: 29603278
[TBL] [Abstract][Full Text] [Related]
13. Impact of plan parameters on the dosimetric accuracy of volumetric modulated arc therapy.
Masi L; Doro R; Favuzza V; Cipressi S; Livi L
Med Phys; 2013 Jul; 40(7):071718. PubMed ID: 23822422
[TBL] [Abstract][Full Text] [Related]
14. Phantomless patient-specific TomoTherapy QA via delivery performance monitoring and a secondary Monte Carlo dose calculation.
Handsfield LL; Jones R; Wilson DD; Siebers JV; Read PW; Chen Q
Med Phys; 2014 Oct; 41(10):101703. PubMed ID: 25281942
[TBL] [Abstract][Full Text] [Related]
15. IMRT QA and gamma comparisons: The impact of detector geometry, spatial sampling, and delivery technique on gamma comparison sensitivity.
Steers JM; Fraass BA
Med Phys; 2021 Sep; 48(9):5367-5381. PubMed ID: 34036596
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems.
Hussein M; Rowshanfarzad P; Ebert MA; Nisbet A; Clark CH
Radiother Oncol; 2013 Dec; 109(3):370-6. PubMed ID: 24100148
[TBL] [Abstract][Full Text] [Related]
17. Biological consequences of MLC calibration errors in IMRT delivery and QA.
Moiseenko V; Lapointe V; James K; Yin L; Liu M; Pawlicki T
Med Phys; 2012 Apr; 39(4):1917-24. PubMed ID: 22482613
[TBL] [Abstract][Full Text] [Related]
18. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
[TBL] [Abstract][Full Text] [Related]
19. Incorrect dosimetric leaf separation in IMRT and VMAT treatment planning: Clinical impact and correlation with pretreatment quality assurance.
Sjölin M; Edmund JM
Phys Med; 2016 Jul; 32(7):918-25. PubMed ID: 27394690
[TBL] [Abstract][Full Text] [Related]
20. Statistical variability and confidence intervals for planar dose QA pass rates.
Bailey DW; Nelms BE; Attwood K; Kumaraswamy L; Podgorsak MB
Med Phys; 2011 Nov; 38(11):6053-64. PubMed ID: 22047370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
